23.06.2023 - VBI Vaccines Inc. (Nasdaq: VBIV) ('VBI' or the 'Company'), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the voting results from its annual general meeting of ... Seite 1